First-in-class small molecule potentiators of cancer virotherapy

The use of engineered viral strains such as gene therapy vectors and oncolytic viruses (OV) to selectively destroy cancer cells is poised to make a major impact in the clinic and revolutionize cancer therapy. In particular, several studies have shown that OV therapy is safe and well tolerated in hum...

詳細記述

保存先:
書誌詳細
出版年:Sci Rep
主要な著者: Dornan, Mark H., Krishnan, Ramya, Macklin, Andrew M., Selman, Mohammed, El Sayes, Nader, Son, Hwan Hee, Davis, Colin, Chen, Andrew, Keillor, Kerkeslin, Le, Penny J., Moi, Christina, Ou, Paula, Pardin, Christophe, Canez, Carlos R., Le Boeuf, Fabrice, Bell, John C., Smith, Jeffrey C., Diallo, Jean-Simon, Boddy, Christopher N.
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2016
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4880900/
https://ncbi.nlm.nih.gov/pubmed/27226390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep26786
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料